Kensey Nash's QuickCat extraction catheter receives CE Mark approval

By Elaine Rigoli

Tampa, Fla., July 24 - Kensey Nash Corp. has received CE Mark approval for its QuickCat extraction catheter, which allows the sale of the product throughout the European Union.

The QuickCat catheter is an aspiration catheter indicated for the removal of fresh soft emboli and thrombi (blood clots) from vessels in the arterial system.

The company said the device will be sold through Kensey Nash's endovascular direct sales force in Germany and through a distribution network for the rest of Europe. The QuickCat catheter will be launched in the European Union within 30 days.

In the United States, the QuickCat catheter received 510(k) clearance in March and is being sold by the company's U.S. endovascular sales force.

Kensey Nash is a medical technology company based in Exton, Pa.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.